FundedIQ
Biotechnology

Domus Diagnostics: Funding, Investors & Team (Nov 2026)

Domus Diagnostics provides a care diagnostics platform that offers respiratory disease home testing services. The company was founded in 2021 and is headquartered in Park City, Utah.

www.domusdx.com Park City, United States 1-10 employees
Biotechnology Health Care Health Diagnostics B2B Diagnostics Poc Home health Infectious diseases
Total raised
$2.4M
Rounds
1
Latest
Undisclosed round
May 2023

Domus Diagnostics has raised $2.4M across 1 funding round on record, the most recent an undisclosed round of $2.4M announced in May 2023.

That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Domus Diagnostics Company Profile and Key Stats

Total funding raised
$2.4M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.4M in May 2023
Employees
1-10
reported band
Headquarters
Park City, United States

Latest funding round on record: May 2023.

Domus Diagnostics Funding Rounds

Date
Round
Amount
Undisclosed round
$2.4M

Domus Diagnostics Founders and Leadership Team

Name
Role
Contact
Paul Chapman
CEO
Locked

Contact details for the Domus Diagnostics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Domus Diagnostics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M

Domus Diagnostics' latest round of $2.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Domus Diagnostics in Biotechnology and Park City

Companies Similar to Domus Diagnostics

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Domus Diagnostics Funding FAQs

What does Domus Diagnostics do?

Domus Diagnostics provides a care diagnostics platform that offers respiratory disease home testing services. The company was founded in 2021 and is headquartered in Park City, Utah.

How much funding has Domus Diagnostics raised?

Domus Diagnostics has raised $2.4M across 1 round on record. The most recent is an undisclosed round of $2.4M announced in May 2023.

When did Domus Diagnostics last raise funding?

Domus Diagnostics' most recent funding round on record is an undisclosed round of $2.4M, announced in May 2023.

Who is the CEO of Domus Diagnostics?

Paul Chapman is listed as CEO at Domus Diagnostics.

Where is Domus Diagnostics headquartered?

Domus Diagnostics is based in Park City, Utah, United States.

How many employees does Domus Diagnostics have?

Domus Diagnostics is in the 1-10 employee band.

How does Domus Diagnostics' funding compare to other Biotechnology startups?

Domus Diagnostics' latest round of $2.4M is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Domus Diagnostics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Domus Diagnostics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.